Singh S, Heien HC, Herrin J, Dulai PS, et al. Comparative Risk of Serious Infections With Tumor Necrosis Factor alpha Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2022;20:e74-e88.
PMID: 33640480